GT Biopharma, Inc. License Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024
License Agreements
GT Biopharma, Inc.
Biotechnology
2024
Exclusive License Agreement with Regents of the University of Minnesota, dated March 26, 2021
License Agreements
GT Biopharma, Inc.
Biotechnology
2022
Exclusive License Agreement between Daniel A. Vallera, Ph.D., Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
License Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2017
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc. (December 31, 2014)
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
License Agreement Between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc. for Technology Rights
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
Exclusive License Agreement between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
License Agreement Between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
Exclusive License Agreement between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2016
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
License Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
Exclusive License Agreement between Daniel A. Vallera, Ph.D., Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2016
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc. (December 31, 2014)
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Amendment No. 2 to Exclusive License and Supply Agreement between OXIS International and HaptoGuard, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
2006